Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R00 HL107749)
Northwestern University Global Health Initiative (UL1TR001422)
Northwestern Global Health Initiative (N/A)
Received: 12 June 2018
Accepted: 16 January 2019
First Online: 6 February 2019
Ethics approval and consent to participate
: This study was approved by applicable institutional review board and ethics committees. Also, written informed consent was obtained from the study patients and providers prior to the data collection.
: All authors approved the submission of this manuscript for publication to BMC Implementation Science.
: Mark Huffman (MH) has received support from the World Heart Federation to serve as its senior program advisor for the Emerging Leaders program, which is supported by unrestricted educational grants from Boehringer-Ingelheim and Novartis and has been previously supported by BUPA and AstraZeneca for work unrelated to this paper. MH also received support from the American Heart Association, Verily, and AstraZeneca for work unrelated to this paper. Dorairaj Prabhakaran (DP) has received support from the National Heart Lung and Blood Institute, Fogarty International Centre, National Cancer Institute, Wellcome Trust, Indian Council of Medical Research and research support from several pharmaceutical companies, but none that is directly related to this submission. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.